These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37276724)

  • 1. Nervonic acid improves liver inflammation in a mouse model of Parkinson's disease by inhibiting proinflammatory signaling pathways and regulating metabolic pathways.
    Wang X; Liang T; Mao Y; Li Z; Li X; Zhu X; Cao F; Zhang J
    Phytomedicine; 2023 Aug; 117():154911. PubMed ID: 37276724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.
    Yuan SN; Wang MX; Han JL; Feng CY; Wang M; Wang M; Sun JY; Li NY; Simal-Gandara J; Liu C
    Phytomedicine; 2023 Apr; 112():154702. PubMed ID: 36764096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated metabolomics and transcriptomics reveal the neuroprotective effect of nervonic acid on LPS-induced AD model mice.
    Wang X; Li Z; Li X; Liu X; YingMao ; Cao F; Zhu X; Zhang J
    Biochem Pharmacol; 2023 Mar; 209():115411. PubMed ID: 36639003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and metabolomic analyses provide insights into the attenuation of neuroinflammation by nervonic acid in MPTP-stimulated PD model mice.
    Wang X; Zhu X; Li X; Li Z; Mao Y; Zhang S; Liu X; Liu X; Liu Y; Cao F; Zhang J
    Food Funct; 2023 Jan; 14(1):277-291. PubMed ID: 36484706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of metabolomic and transcriptomic profiling reveals the effect of Buyang Huanwu decoction on Parkinson's disease in mice.
    Hu J; Li P; Han H; Ji P; Zhao X; Li Z
    Phytomedicine; 2023 Jun; 114():154755. PubMed ID: 36948142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D; Fu S; Ye B; Wang H; He Y; Li Z; Li J; Gao X; Liu D
    J Neuroinflammation; 2023 Mar; 20(1):86. PubMed ID: 36991440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EriB targeted inhibition of microglia activity attenuates MPP
    Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
    Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Brain Metabolomics and Network Pharmacology Analysis to Reveal the Improvement Effect of Bai Chan Ting on Parkinson's Disease.
    Zhang N; Fu J; Gao X; Lu F; Lu Y; Liu S
    Biomed Res Int; 2022; 2022():6113093. PubMed ID: 36523484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nervonic acid amends motor disorder in a mouse model of Parkinson's disease.
    Hu D; Cui Y; Zhang J
    Transl Neurosci; 2021 Jan; 12(1):237-246. PubMed ID: 34055392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson's Disease Through the CXCL12/CXCR4 Signaling Pathway.
    Ma J; Wang Z; Chen S; Sun W; Gu Q; Li D; Zheng J; Yang H; Li X
    Mol Neurobiol; 2021 Mar; 58(3):913-925. PubMed ID: 33057926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated study of metabolomics and transcriptomics to reveal the anti-primary dysmenorrhea mechanism of Akebiae Fructus.
    Ma B; Yang S; Tan T; Li J; Zhang X; Ouyang H; He M; Feng Y
    J Ethnopharmacol; 2021 Apr; 270():113763. PubMed ID: 33383110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
    Huang YY; Zhang Q; Zhang JN; Zhang YN; Gu L; Yang HM; Xia N; Wang XM; Zhang H
    Brain Behav Immun; 2018 Jul; 71():93-107. PubMed ID: 29649522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.